NeoGenomics Announces Executive Leadership and Board of Directors Succession Plan
NeoGenomics announced a planned leadership transition effective January 4, 2027, naming Warren Stone CEO and Tony Zook Executive Chairman, with related Board changes. The company also provided preliminary, unaudited third quarter results and said preliminary third quarter total revenue was expected to be approximately $209 million with NGS revenue growth of approximately 28%, and indicated an expected increase to full year total revenue guidance at the midpoint.